Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-13-013064
Filing Date
2013-10-15
Accepted
2013-10-15 16:06:28
Documents
11
Period of Report
2013-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q blud20130831_10q.htm 10-Q 1581386
2 EXHIBIT 31.1 ex31-1.htm EX-31 13292
3 EXHIBIT 31.2 ex31-2.htm EX-31 13832
4 EXHIBIT 32.1 ex32-1.htm EX-32 6350
5 EXHIBIT 32.2 ex32-2.htm EX-32 6159
  Complete submission text file 0001437749-13-013064.txt   14179632

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS blud-20130831.xml EX-101.INS 3040232
7 EXHIBIT 101.SCH blud-20130831.xsd EX-101.SCH 77313
8 EXHIBIT 101.CAL blud-20130831_cal.xml EX-101.CAL 58708
9 EXHIBIT 101.DEF blud-20130831_def.xml EX-101.DEF 303683
10 EXHIBIT 101.LAB blud-20130831_lab.xml EX-101.LAB 476452
11 EXHIBIT 101.PRE blud-20130831_pre.xml EX-101.PRE 309693
Mailing Address 3130 GATEWAY DR P O BOX 5625 NORCROSS GA 30091-5625
Business Address 3130 GATWAY PO BOX 5625 NORCROSS GA 30091 770 441 2051
IMMUCOR INC (Filer) CIK: 0000736822 (see all company filings)

EIN.: 222408354 | State of Incorp.: GA | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-14820 | Film No.: 131151997
SIC: 2835 In Vitro & In Vivo Diagnostic Substances